Xenome—a tool for classifying reads from xenograft samples
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Motivation: Shotgun sequence read data derived from xenograft material contains a mixture of reads arising from the host and reads arising from the graft. Classifying the read mixture to separate the two allows for more precise analysis to be performed. Results: We present a technique, with an associated tool Xenome, which performs fast, accurate and specific classification of xenograft-derived sequence read data. We have evaluated it on RNA-Seq data from human, mouse and human-in-mouse xenograft datasets. Availability: Xenome is available for non-commercial use from http://www.nicta.com.au/bioinformatics Contact: tom.conway@nicta.com.au
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For the demultiplexing of species, tools have been developed, e.g. for the purpose of identifying the contribution of mouse cells to human xenografts tumours [50, 51].”
From Benchmarking of computational demultiplexing methods for single-nucleus RNA sequencing data (2025) · cites this paper as [51]
The cited source says what the claim attributes to it.
In the citing paper
“like Xenome, which can perform fast, accurate and specific classification of sequence reads [80]”
From Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive Review (2026) · cites this paper as [80]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, there have been multiple reports demonstrating differences in the ability of KRAS G12D to more effectively facilitate PI3K effector interactions and pathway activation compared with KRAS G12C or other KRAS variants providing further rationale for the co-targeting strategy with direct PI3K α inhibitors in KRAS G12D mutant cancers independently of tumor type [39, 40].”
From Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor (2022) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
De novo assembly of human genomes with massively parallel short read sequencing
Li, R., Zhu, H., Ruan, J., Qian, W., Fang, X., Shi, Z., Li, Y., Li, S., Shan, G., Kristiansen, K., et al. (2010) · Genome Research · doi:10.1101/gr.097261.109 · Cited by 2,926 · cited 1×
“We note that in the context of non-uniform RNA-Seq data ignoring the contribution of the murine expression can lead biases. for a variety of purposes, including the classification task present .”
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139 · cited 1×
“Ding et al. (2010) use short read sequencing to study a cancer genome and identify mutations/deletions.”
Pagh, R., & Rodler, F. F. (2004) · Journal of Algorithms · doi:10.1016/j.jalgor.2003.12.002 · Cited by 1,045
Identification of novel transcripts in annotated genomes using RNA-Seq
Roberts, A., Pimentel, H., Trapnell, C., & Pachter, L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr355 · Cited by 972
How to Construct Pseudorandom Permutations from Pseudorandom Functions
Luby, M., & Rackoff, C. (1988) · SIAM Journal on Computing · doi:10.1137/0217022 · Cited by 938
Practical Entropy-Compressed Rank/Select Dictionary
Okanohara, D., & Sadakane, K. (2007) · 2007 Proceedings of the Ninth Workshop on Algorithm Engineering and Experiments (ALENEX) · doi:10.1137/1.9781611972870.6 · Cited by 265
Next-generation VariationHunter: combinatorial algorithms for transposon insertion discovery
Hormozdiari, F., Hajirasouliha, I., Dao, P., Hach, F., Yorukoglu, D., Alkan, C., Eichler, E. E., & Sahinalp, S. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq216 · Cited by 207
Cited by
Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194
Chromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593
Gettinger, S., Choi, J., Hastings, K., Truini, A., Datar, I., Sowell, R., Wurtz, A., Dong, W., Cai, G., Melnick, M. A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0593 · Cited by 787
“For analysis of the PDXs, we used Xenome to classify the sequence reads and filter out the mouse sequence reads prior to alignment (46).”
MethodInterrogating open issues in cancer precision medicine with patient-derived xenografts
Byrne, A. T., Alférez, D. G., Amant, F., Annibali, D., Arribas, J., Biankin, A. V., Bruna, A., Budinská, E., Caldas, C., Chang, D. K., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.140 · Cited by 657
“…from molecular profiling, and could require the application of specific algorithms for signal correction to avoid or reduce artefacts and biases 156,169 . be subsequently used to identify one or more ‘biofacsimile’ or ‘proxy’ PDX models for individual patients, and PDX-associated information may…”
Stromal contribution to the colorectal cancer transcriptome
Isella, C., Terrasi, A., Bellomo, S. E., Petti, C., Galatola, G., Muratore, A., Mellano, A., Senetta, R., Cassenti, A., Sonetto, C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3224 · Cited by 640
Tobacco smoking and somatic mutations in human bronchial epithelium
Yoshida, K., Gowers, K. H. C., Lee-Six, H., Chandrasekharan, D. P., Coorens, T., Maughan, E. F., Beal, K., Menzies, A., Millar, F. R., Anderson, E., et al. (2020) · Nature · doi:10.1038/s41586-020-1961-1 · Cited by 521
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
Hallin, J., Bowcut, V., Calinisan, A., Briere, D. M., Hargis, L., Engstrom, L. D., Laguer, J., Medwid, J., Vanderpool, D., Lifset, E., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02007-7 · Cited by 553
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 341
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Fischer, G. M., Jalali, A., Kircher, D. A., Lee, W.-C., McQuade, J. L., Haydu, L. E., Joon, A. Y., Reuben, A., de Macedo, M. P., Carapeto, F. C. L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1489 · Cited by 329
deCarvalho, A. C., Kim, H., Poisson, L. M., Winn, M. E., Mueller, C., Cherba, D., Koeman, J., Seth, S., Protopopov, A., Felicella, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0105-0 · Cited by 318
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
Russo, M., Misale, S., Wei, G., Siravegna, G., Crisafulli, G., Lazzari, L., Corti, G., Rospo, G., Novara, L., Mussolin, B., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0940 · Cited by 308
“Xenome software (25) was applied to remove murine sequences from xenopatient samples prior to alignment.”
MethodOrganoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
Shi, R., Radulovich, N., Ng, C., Liu, N., Notsuda, H., Cabanero, M., Martins-Filho, S. N., Raghavan, V., Li, Q., Mer, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1376 · Cited by 316
“Xenome (29) was used to eliminate reads pertaining to mouse stroma.”
MethodDistinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Lomberk, G., Blum, Y., Nicolle, R., Nair, A., Gaonkar, K. S., Marisa, L., Mathison, A., Sun, Z., Yan, H., Elarouci, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04383-6 · Cited by 261
“We found the majority of super-enhancers to be specific for classical samples (250), including a substantial number of loci (28) associated with TFs, whereas only a few super-enhancers (30) were specific to basal samples.”
BackgroundThe androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Hickey, T. E., Selth, L. A., Chia, K. M., Laven-Law, G., Milioli, H. H., Roden, D., Jindal, S., Hui, M., Finlay-Schultz, J., Ebrahimie, E., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01168-7 · Cited by 257
Deciphering the complex role of thrombospondin-1 in glioblastoma development
Daubon, T., Léon, C., Clarke, K., Andrique, L., Salabert, L., Darbo, E., Pineau, R., Guérit, S., Maitre, M., Dedieu, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08480-y · Cited by 227
Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0909 · Cited by 227
“Mouse sequencing reads were removed using Xenome (12) prior to mutation calling.”
MethodNori, S., Okada, Y., Nishimura, S., Sasaki, T., Itakura, G., Kobayashi, Y., Renault-Mihara, F., Shimizu, A., Koya, I., Yoshida, R., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.006 · Cited by 220
“Mouse and human mRNA sequences were separated using Xenome software (Conway et al., 2012), and separated mRNA-seq data were mapped to the corresponding genomic DNA sequences (human [hg19] and mouse [mm9]) using TopHat software (Trapnell et al., 2009).”
MethodAnderson, M., Marayati, R., Moffitt, R., & Yeh, J. J. (2017) · Oncotarget · doi:10.18632/oncotarget.9760 · Cited by 193
PDXNET Consortium, Woo, X. Y., EurOPDX Consortium, Giordano, J., Srivastava, A., Zhao, Z.-M., Lloyd, M. W., de Bruijn, R., Suh, Y.-S., Patidar, R., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00750-6 · Cited by 190
Potassium channel dysfunction in human neuronal models of Angelman syndrome
Sun, A. X., Yuan, Q., Fukuda, M., Yu, W., Yan, H., Lim, G. G. Y., Nai, M. H., D’Agostino, G. A., Tran, H.-D., Itahana, Y., et al. (2019) · Science · doi:10.1126/science.aav5386 · Cited by 178
Menghi, F., Barthel, F. P., Yadav, V., Tang, M., Ji, B., Tang, Z., Carter, G. W., Ruan, Y., Scully, R., Verhaak, R. G. W., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.008 · Cited by 174
“Potential mouse contaminant reads were removed using Xenome (Conway et al., 2012).”
MethodRegenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis
Rao, W., Wang, S., Duleba, M., Niroula, S., Goller, K., Xie, J., Mahalingam, R., Neupane, R., Liew, A.-A., Vincent, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.047 · Cited by 168
“Xenome--a tool for classifying reads from xenograft samples.”
InfluentialXenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data
Kluin, R. J. C., Kemper, K., Kuilman, T., de Ruiter, J. R., Iyer, V., Forment, J. V., Cornelissen-Steijger, P., de Rink, I., ter Brugge, P., Song, J.-Y., et al. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2353-5 · Cited by 162
“Similar challenges are observed when sequencing RNA: beside false positive SNVs, the gene expression levels are often obscured by reads that derive from mouse cells [19].”
BackgroundMethodInfluentialLineage tracing of human development through somatic mutations
Spencer Chapman, M., Ranzoni, A. M., Myers, B., Williams, N., Coorens, T. H. H., Mitchell, E., Butler, T., Dawson, K. J., Hooks, Y., Moore, L., et al. (2021) · Nature · doi:10.1038/s41586-021-03548-6 · Cited by 167
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
Cantley, J. L., Ye, X., Rousseau, E., Januario, T., Hamman, B. D., Rose, C. M., Cheung, T. K., Hinkle, T. B., Soto, L., Quinn, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34562-5 · Cited by 163
Wang, K., Zhang, Q., Li, D., Ching, K. A., Zhang, C., Zheng, X., Ozeck, M., Shi, S. T., Li, X., Wang, H., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1348 · Cited by 170
“Raw RNA-seq reads were filtered using Xenome (22) to remove potential reads from contaminating mouse cells.”
MethodA Wnt-Induced Phenotypic Switch in Cancer-Associated Fibroblasts Inhibits EMT in Colorectal Cancer
Mosa, M. H., Michels, B. E., Menche, C., Nicolas, A. M., Darvishi, T., Greten, F. R., & Farin, H. F. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0263 · Cited by 150
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Klomp, J. A., Klomp, J. E., Stalnecker, C. A., Bryant, K. L., Edwards, A. C., Drizyte-Miller, K., Hibshman, P. S., Diehl, J. N., Lee, Y. S., Morales, A. J., et al. (2024) · Science · doi:10.1126/science.adk0775 · Cited by 120
“0.1) ( 58 ) to classify human and mouse reads.”
BackgroundInfluentialTissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer
Teng, S., Li, Y. E., Yang, M., Qi, R., Huang, Y., Wang, Q., Zhang, Y., Chen, S., Li, S., Lin, K., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0259-z · Cited by 151
Farin, H. F., Mosa, M. H., Ndreshkjana, B., Grebbin, B. M., Ritter, B., Menche, C., Kennel, K. B., Ziegler, P. K., Szabó, L., Bollrath, J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0050 · Cited by 120
“The top 20 signatures based on the adjusted P value were used to extract sample-or context-specific signatures and to create heat maps using the Complex-Heatmap R package (RRID:SCR_017270; version 2.8.0).”
MethodInfluentialThe tandem duplicator phenotype as a distinct genomic configuration in cancer
Menghi, F., Inaki, K., Woo, X., Kumar, P., Grzȩda, K. R., Malhotra, A., Yadav, V. K., Kim, H., Márquez, E. J., Ucar, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520010113 · Cited by 124
Choi, Y. Y., Lee, J. E., Kim, H., Sim, M. H., Kim, K.-K., Lee, G., Kim, H., An, J. Y., Hyung, W. J., Kim, C. B., et al. (2016) · Scientific Reports · doi:10.1038/srep22172 · Cited by 115
Stadler, M., Pudelko, K., Biermeier, A., Walterskirchen, N., Gaigneaux, A., Weindorfer, C., Harrer, N. E., Klett, H., Hengstschläger, M., Schüler, J. B., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.006 · Cited by 121
Scabia, V., Ayyanan, A., Martino, F. D., Agnoletto, A., Battista, L., László, C., Ifticene‐Treboux, A., Zaman, K., Stravodimou, A., Jallut, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30898-0 · Cited by 115
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma
Randall, E. C., Lopez, B. G. C., Peng, S., Regan, M. S., Abdelmoula, W. M., Basu, S. S., Santagata, S., Yoon, H., Haigis, M. C., Agar, J. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0638 · Cited by 94
“We used xenome (21) tool to classify reads into human, mouse, both, unmapped, and ambiguous categories.”
MethodHIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
Fang, D. D., Zhang, B., Gu, Q., Lira, M. E., Xu, Q., Sun, H., Qian, M., Sheng, W., Ozeck, M., Wang, Z., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000087 · Cited by 95
“Human sequence reads were isolated from the mixture of reads arising from the mouse host and reads arising from xenograft tumors by using a specific tool Xenome.(24) The purified reads were then mapped to the Ensembl GRCh37.”
MethodPan, C.-X., Zhang, H., Tepper, C. G., Lin, T., Davis, R. R., Keck, J., Ghosh, P., Gill, P. S., Airhart, S. D., Bult, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134346 · Cited by 97
“Sequence reads (FASTQ format) were classified as human (graft) or mouse (host) using Xenome [18] and subsequently aligned to the reference human genome assembly (Feb.”
InfluentialWang, D. Y. Q., Pham, N., Tong, J., Sakashita, S., Allo, G., Kim, L., Yanagawa, N., Raghavan, V., Wei, Y., To, C., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30472 · Cited by 89
Ahdesmäki, M. J., Gray, S. R., Johnson, J. H., & Lai, Z. (2016) · F1000Research · doi:10.12688/f1000research.10082.1 · Cited by 86
Evolutionary histories of breast cancer and related clones
Nishimura, T., Kakiuchi, N., Yoshida, K., Sakurai, T., Kataoka, T. R., Kondoh, E., Chigusa, Y., Kawai, M., Sawada, M., Inoue, T., et al. (2023) · Nature · doi:10.1038/s41586-023-06333-9 · Cited by 96
Kawai, M., Imaizumi, K., Ishikawa, M., Shibata, S., Shinozaki, M., Shibata, T., Hashimoto, S., Kitagawa, T., Ago, K., Kajikawa, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110019 · Cited by 92
Sze, K. M., Ho, D. W., Chiu, Y., Tsui, Y., Chan, L., Lee, J. M., Chok, K., Chan, A. C. Y., Tang, C. N., Tang, V. W., et al. (2020) · Hepatology · doi:10.1002/hep.31231 · Cited by 86
“All HCC cell lines used were authenticated by short tandem repeat assays and a computation algorithm(9) and confirmed to have no HeLa cell and mouse cell contamination.”
MethodGan, S., Macalinao, D. G., Shahoei, S. H., Tian, L. H., Jin, X., Basnet, H., Bibby, C., Muller, J., Atri, P., Seffar, E., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.015 · Cited by 103
Liu, B., Li, L., Yang, G., Geng, C., Luo, Y., Wu, W., Manyam, G. C., Korentzelos, D. K., Park, S., Tang, Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0317 · Cited by 82
“Xenome was used to classify the xenograft sequence data into corresponding tumor and mouse reads (25).”
MethodBusuttil, R. A., George, J., Tothill, R. W., Ioculano, K., Kowalczyk, A., Mitchell, C., Lade, S., Tan, P. B. O., Haviv, I., & Boussioutas, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3049 · Cited by 88
“Using species-specific expressionprofiling,we and others found that some genes in stromal reaction signatures are in fact expressed by epithelial cancer cells (32, 33).”
BackgroundA comprehensive long-read isoform analysis platform and sequencing resource for breast cancer
Veiga, D. F. T., Nesta, A. V., Zhao, Y., Mays, A. D., Huynh, R., Rossi, R., Wu, T.-C., Palucka, K., Anczuków, O., Beck, C. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abg6711 · Cited by 87
Transcriptomic Hallmarks of Tumor Plasticity and Stromal Interactions in Brain Metastasis
Wingrove, E., Liu, Z. Z., Patel, K. D., Estape, A. A., Cai, W. L., Melnick, M., Politi, K. A., Monteiro, C., Zhu, L., Valiente, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.085 · Cited by 69
“Recent methodological advances in the analysis of mammalian transcriptomes have improved our ability to accurately map species-specific gene transcripts of low abundance in tissues (Conway et al., 2012; Khandelwal et al., 2017).”
BackgroundCallari, M., Batra, A. S., Batra, R. N., Sammut, S., Greenwood, W., Clifford, H., Hercus, C., Chin, S., Bruna, A., Rueda, O. M., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4414-y · Cited by 64
“As a final step, we wanted to compare our approach with previously described methods, in particular Disam-biguate [12] and Xenome [11].”
BackgroundMethodResultInfluentialEvrard, Y. A., Srivastava, A., Randjelović, J., Arunachalam, S., Bult, C. J., Chen, H., Chen, L., Davies, M., Davies, S., Davis‐Dusenbery, B. N., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3101 · Cited by 64
Schneeberger, V. E., Allaj, V., Gardner, E. E., Poirier, J. T., & Rudin, C. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160587 · Cited by 62
Reproducible bioinformatics project: a community for reproducible bioinformatics analysis pipelines
Kulkarni, N., Alessandrì, L., Panero, R., Arigoni, M., Olivero, M., Ferrero, G., Cordero, F., Beccuti, M., & Calogero, R. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2296-x · Cited by 87
“3b), based on xenome software [18], to discriminate between human reads and mouse host reads in the sequences produced by the analysis of patients derived xenografts (PDX, [19]).”
BackgroundGemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
Bulle, A. S., Dekervel, J., Deschuttere, L., Nittner, D., Libbrecht, L. J., Janky, R., Plaisance, S., Topal, B., Coosemans, A., Lambrechts, D., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.01.004 · Cited by 64
“Important to note, the ICRG is quite simple to implement compared to Xenome.”
MethodInfluentialEvolving neoantigen profiles in colorectal cancers with DNA repair defects
Rospo, G., Lorenzato, A., Amirouchene-Angelozzi, N., Magrì, A., Cancelliere, C., Corti, G., Negrino, C., Amodio, V., Montone, M., Bartolini, A., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0654-6 · Cited by 60
Ali, Z., Vildevall, M., Rodriguez, G. V., Tandiono, D., Vamvakaris, I. N., Evangelou, G., Lolas, G., Syrigos, K. N., Villanueva, A., Wick, M. J., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02280-x · Cited by 62
“Next, human reads were isolated using Xenome [34], aligned to the GRCh38 reference genome, and mutations were called using a workflow based on GATK (Genome Analysis Toolkit version 4) best practices.”
MethodKim, B. R., de Laar, E. V., Cabanero, M., Tarumi, S., Hasenöder, S., Wang, D. Y. Q., Virtanen, C., Suzuki, T., Bandarchi, B., Sakashita, S., et al. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002581 · Cited by 58
Gendoo, D. M. A., Denroche, R. E., Zhang, A. X. W., Radulovich, N., Jang, G. H., Lemire, M., Fischer, S. E., Chadwick, D. E., Lungu, I. M., Ibrahimov, E., et al. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006596 · Cited by 57
Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models
Khandelwal, G., Girotti, M. R., Smowton, C., Taylor, S., Wirth, C., Dynowski, M., Frese, K. K., Brady, G., Dive, C., Marais, R., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0431 · Cited by 56
“Variousstudieshave reported the need to preprocess xenograft data before performing downstream analysis (9, 13).”
BackgroundMethodMirhadi, S., Tam, S., Li, Q., Moghal, N., Pham, N., Tong, J., Golbourn, B. J., Krieger, J. R., Taylor, P. P., Li, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29444-9 · Cited by 58
The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat
Kurz, S., Thieme, R., Amberg, R., Groth, M., Jahnke, H., Pieroh, P., Horn, L., Kolb, M., Huse, K., Platzer, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189514 · Cited by 62
“For separating the mice and human tissue derived reads in the xenografted samples they were introduced into the tool xenome [68].”
MethodWoo, X. Y., Srivastava, A., Graber, J. H., Yadav, V. K., Sarsani, V., Simons, A., Beane, G., Grubb, S. C., Ananda, G., Liu, R., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0551-2 · Cited by 51
Tumour microenvironment 3D-modelling: simplicity to complexity and back again
Carter, E. P., Roozitalab, R., Gibson, S. V., & Grose, R. P. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.06.009 · Cited by 52
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology
Corti, G., Bartolini, A., Crisafulli, G., Novara, L., Rospo, G., Montone, M., Negrino, C., Mussolin, B., Buscarino, M., Isella, C., et al. (2019) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.02.008 · Cited by 51
Wang, H., Tian, L. H., Goldstein, A., Liu, J., Lo, H.-C., Sheng, K., Welte, T., Wong, S. T. C., Gugala, Z., Stossi, F., et al. (2017) · Nature Communications · doi:10.1038/ncomms15045 · Cited by 48
“RNA-seq next-generation sequencing reads derived from xenograft materials containing a mixture of human and mouse reads were separated using Xenome (version 1.0.1) 51 .”
InfluentialEstablishment of patient derived xenografts as functional testing of lung cancer aggressiveness
Moro, M., Bertolini, G., Caserini, R., Borzi, C., Boeri, M., Fabbri, A., Leone, G., Gasparini, P., Galeone, C., Pelosi, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06912-7 · Cited by 44
Transcriptional dissection of pancreatic tumors engrafted in mice
Martinez-Garcia, R., Juan, D., Rausell, A., Muñoz, M., Baños, N., Menéndez, C., Lopez-Casas, P. P., Rico, D., Valencia, A., & Hidalgo, M. M. (2014) · Genome Medicine · doi:10.1186/gm544 · Cited by 50
Lenting, K., Khurshed, M., Peeters, T. H., van den Heuvel, C. N. A. M., van Lith, S. A. M., de Bitter, T. J. J., Hendriks, W. J. A. J., Span, P. N., Molenaar, R. J., Botman, D., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800907rr · Cited by 46
“Xenome-based RNAseq analysis of the human transcripts in E478 and E434 xenografts confirmed the differences in expression profiles of metabolic genes that we found in our cohort of clinical gliomas, except for the GABA-shunt enzymes GAD-1,whichwas expressedat4-fold lower levels inE478 than in E434, and ABAT, which was…”
BackgroundMethodInfluentialBradford, J. R., Wappett, M., Beran, G. J., Logié, A., Delpuech, O., Brown, H., Boros, J., Camp, N. J., McEwen, R. K., Mazzola, A. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8014 · Cited by 42
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
Achinger-Kawecka, J., Stirzaker, C., Portman, N., Campbell, E. M., Chia, K.-M., Du, Q., Laven‐Law, G., Nair, S. S., Yong, A., Wilkinson, A., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01181-7 · Cited by 47
Chou, J., Fitzgibbon, M., Mortales, C., Towlerton, A. M. H., Upton, M. P., Yeung, R. S. W., McIntosh, M. W., & Warren, E. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079874 · Cited by 40
“97% of sequence reads with a high degree of confidence similar to what has been reported with another bi-species alignment algorithm for RNA-seq data from xenografts [33].”
ResultFast lightweight accurate xenograft sorting
Zentgraf, J., & Rahmann, S. (2021) · Algorithms for Molecular Biology · doi:10.1186/s13015-021-00181-w · Cited by 38
“This idea extends the k-mer classification of xenome (7), where a k-mer can be host, graft, both, or marginal, the latter category comprising both our weak host and weak graft k-mers.”
BackgroundMethodInfluentialKim, H. R., Kang, H. N., Yun, M. R., Ju, K. Y., Choi, J. W., Jung, D. M., Pyo, K., Hong, M. H., Ahn, M.-J., Sun, J., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01074-2 · Cited by 41
Zhu, L., Retana, D., García‐Gómez, P., Álvaro‐Espinosa, L., Priego, N., Masmudi‐Martín, M., Yebra, N., Miarka, L., Hernández-Encinas, E., Blanco‐Aparicio, C., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114552 · Cited by 43
“The resulting reads were fed to Xenome (Conway et al, 2012) to separate the xenograft-derived human and mouse reads.”
MethodKohli, M., Wang, L., Xie, F., Sicotte, H., Yin, P., Dehm, S. M., Hart, S. N., Vedell, P. T., Barman, P., Qin, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145176 · Cited by 36
“For both DNA and RNA, we employed the classification scheme proposed by Conway et al. [28], which classifies reads as “graft”, “host”, “both”, “neither” or “ambiguous”.”
InfluentialHynds, R. E., Huebner, A., Pearce, D. R., Hill, M. S., Akarca, A. U., Moore, D. A., Ward, S., Gowers, K. H. C., Karasaki, T., Bakir, M. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47547-3 · Cited by 37
Laverty, D. J., Gupta, S. K., Bradshaw, G. A., Hunter, A. S., Carlson, B. L., Calmo, N. M., Chen, J., Tian, S., Sarkaria, J. N., & Nagel, Z. D. (2024) · Nature Communications · doi:10.1038/s41467-024-49316-8 · Cited by 46
Ichimura, H., Kadota, S., Kashihara, T., Yamada, M., Ito, K., Kobayashi, H., Tanaka, Y., Shiba, N., Chuma, S., Tohyama, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68373-9 · Cited by 36
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
Gündel, B., Liu, X., Löhr, M. J., & Heuchel, R. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741162 · Cited by 47
“Alternative to pre-labeling, different cell types can also be vitrually “sorted” after cultivation by using cells from different species and exploiting the small differences in species specific DNA/RNA sequences (Conway et al., 2012; Liu et al., 2021).”
BackgroundCloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis
Wang, S., Rao, W. H., Hoffman, A., Lin, J. M., Li, J., Lin, T., Liew, A.-A., Vincent, M., Mertens, T. C. J., Karmouty‐Quintana, H., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abp9528 · Cited by 38
Bradford, J. R., Farren, M. R., Powell, S. J., Runswick, S. K., Weston, S. L., Brown, H. J., Delpuech, O., Wappett, M., Smith, N. R., Carr, T. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066003 · Cited by 32
“Recently, a statistical method to pre-assign short reads to their species of origin prior to mapping has been proposed [30].”
Sato, R., Nakano, T., Hosonaga, M., Sampetrean, O., Harigai, R., Sasaki, T., Koya, I., Okano, H., Kudoh, J., Saya, H., et al. (2017) · BioMed Research International · doi:10.1155/2017/8032910 · Cited by 36
“Mouse and human mRNA sequences were separatedwith the use ofXenome software [21].”
MethodPetrosyan, V., Dobrolecki, L. E., Thistlethwaite, L. R., Lewis, A. N., Sallas, C., Srinivasan, R. R., Lei, J. T., Kovačević, V., Obradović, P., Ellis, M. J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105799 · Cited by 40
Establishing prostate cancer patient derived xenografts: Lessons learned from older studies
Russell, P. J., Russell, P., Rudduck, C., Tse, B. W., Williams, E. D., & Raghavan, D. (2015) · The Prostate · doi:10.1002/pros.22946 · Cited by 39
Self-citationMcNamara, B. C., Demirkiran, C., Hartwich, T. M. P., Bellone, S., Manavella, D. D., Mutlu, L., Greenman, M. P., Zipponi, M., Yang‐Hartwich, Y., Yang, Y., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.01.028 · Cited by 44
Targeting HER 2 in patient‐derived xenograft ovarian cancer models sensitizes tumors to chemotherapy
Harris, F. R., Zhang, P., Yang, L., Hou, X., Leventakos, K., Weroha, S. J., Vasmatzis, G., & Kovtun, I. V. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12414 · Cited by 39
“Briefly, raw reads from PDX samples were first processed with XENOME (version 1.0.1) (Conway et al., 2012) to be classified as ‘mouse’ or ‘human’.”
MethodInfluentialAlcaniz, J., Winkler, L., Dahlmann, M., Becker, M., Orthmann, A., Haybaeck, J., Krassnig, S., Skofler, C., Kratzsch, T., Kuhn, S. A., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1129627 · Cited by 42
Campbell, K. M., Lin, T., Zolkind, P., Barnell, E. K., Skidmore, Z. L., Winkler, A. E., Law, J. H., Mardis, E. R., Wartman, L. D., Adkins, D. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.058 · Cited by 34
“…the human reference genome (National Center for Biotechnology Information [NCBI] build 38, GRCh38) and the mouse reference genome (Genome Reference Consortium Mouse Build 38, mm10) using the Xenome (version 1.0.0) software in order to filter mouse reads from human reads (Conway et al., 2012).”
InfluentialYap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Mudianto, T., Campbell, K. M., Webb, J., Zolkind, P., Skidmore, Z. L., Riley, R., Barnell, E. K., Ozgenc, I., Giri, T., Dunn, G. P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-4179 · Cited by 33
Pham, N., Radulovich, N., Ibrahimov, E., Martins-Filho, S. N., Li, Q., Pintilie, M., Weiss, J., Raghavan, V., Cabanero, M., Denroche, R. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90049-1 · Cited by 36
Next-Generation Sequence Analysis of Cancer Xenograft Models
Rossello, F. J., Tothill, R. W., Britt, K. L., Marini, K. D., Falzon, J., Thomas, D. M., Peacock, C. D., Marchionni, L., Li, J., Bennett, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074432 · Cited by 33
“Although this approach was previously reported for RNA-Seq [9,10], the authors did not describe a detailed workflow for the deep sequencing technologies mentioned above.”
BackgroundMethodInfluentialWidespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway
Harmston, N., Lim, J. Y. S., Arqués, O., Pálmer, H. G., Petretto, E. G., Virshup, D. M., & Madan, B. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2129 · Cited by 34
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts
Hu, B., Wiesehöfer, M., de Miguel, F. J., Liu, Z. Z., Chan, L.-H., Choi, J., Melnick, M. A., Estape, A. A., Walther, Z., Zhao, D., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-0438 · Cited by 31
Cybulska, P., Stewart, J. M., Sayad, A., Virtanen, C., Shaw, P. A., Clarke, B. A., Stickle, N. H., Bernardini, M. Q., & Neel, B. G. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.019 · Cited by 35
Chen, G. T., Tifrea, D. F., Murad, R., Habowski, A. N., Lyou, Y., Duong, M. R., Hosohama, L., Mortazavi, A., Edwards, R. A., & Waterman, M. L. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0349 · Cited by 33
Mixed-species RNA-seq for elucidation of non-cell-autonomous control of gene transcription
Qiu, J. L., Dando, O., Baxter, P. S., Hasel, P., Heron, S., Simpson, T. I., & Hardingham, G. E. (2018) · Nature Protocols · doi:10.1038/s41596-018-0029-2 · Cited by 33
Ko, Y.-C., Lai, T.-Y., Hsu, S.-C., Wang, F.-H., Su, S.-Y., Chen, Y.-L., Tsai, M.-L., Wu, C.-C., Hsiao, J., Chang, J., et al. (2020) · Cancers · doi:10.3390/cancers12071718 · Cited by 29
XenoCell: classification of cellular barcodes in single cell experiments from xenograft samples
Cheloni, S., Hillje, R., Luzi, L., Pelicci, P. G., & Gatti, E. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00872-8 · Cited by 28
“In this step, XenoCell takes advantage of Xenome (Conway, 2012) to ensure highly accurate classification.”
MethodInfluentialXie, T., Musteanu, M., Lopez-Casas, P. P., Shields, D. J., Olson, P., Rejto, P. A., & Hidalgo, M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142631 · Cited by 29
Glaser, G. E., Weroha, S. J., Becker, M. A., Hou, X., Enderica-Gonzalez, S., Harrington, S. C., & Haluska, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126867 · Cited by 27
“To account for mouse genomic DNA, the Xenome tool [29] was used to classify sequence read data as either human or mouse genome.”
MethodAssessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
Guilhamon, P., Butcher, L. M., Presneau, N., Wilson, G. A., Feber, A., Paul, D. S., Schütte, M., Haybaeck, J., Keilholz, U., Hoffman, J., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0116-0 · Cited by 28
Tso, K.-Y., Lee, S. D., Lo, K. W., & Yip, K. Y.-L. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1172 · Cited by 26
“proposed two computational methods for classifying human and mouse reads [10], which were tested on RNA-seq data from human, mouse, and human-in-mouse xenografts.”
Method
Metadata
- Authors
- Conway, T., Wazny, J., Bromage, A., Tymms, M., Sooraj, D., Williams, E. D., & Beresford-Smith, B.
- Affiliations
- The University of Melbourne (AU)
- 1 NICTA Victoria Research Laboratory, Department of Computer Science and Software Engineering, The University of Melbourne, Parkville and 2Monash Institute of Medical Research, Monash University, Clayton, Australia
- Corresponding author
- Conway, Thomas
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-09
- Volume
- 28
- Issue
- 12
- Pages
- i172-i178
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- PMC
- PMC3371868
- OpenAlex
- W2108976255
- Cited by
- 276
- References
- 17
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 29 · 2023: 31 · 2022: 32 · 2021: 34 · 2020: 20 · 2019: 22 · 2018: 26 · 2017: 12 · 2016: 11 · 2015: 16 · 2014: 6 · 2013: 5 · 2012: 1
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioinformatics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Figshare (submittedVersion, cc-by-nc)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Funders
- Prostate Cancer Foundation
- National ICT Australia
- Australian Government
- Prostate Cancer Foundation of Australia
- State Government of Victoria
- National Health and Medical Research Council (519539)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- xenografts, read classification, RNA-seq, shotgun sequencing, bioinformatics software
- MeSH terms
- Algorithms, Animals, Humans, Software, Transplantation, Heterologous, Genome, Sequence Analysis, RNA, DNA, Complementary, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.